- Home
- RSSS vs ALRN Comparison
RSSS vs ALRN Comparison
Compare RSSS & ALRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- ALRN
- Stock Information
- Founded
- RSSS 2006
- ALRN 2001
- Country
- RSSS United States
- ALRN United States
- Employees
- RSSS N/A
- ALRN N/A
- Industry
- RSSS Business Services
- ALRN Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- ALRN Health Care
- Exchange
- RSSS Nasdaq
- ALRN Nasdaq
- Market Cap
- RSSS 86.4M
- ALRN 76.9M
- IPO Year
- RSSS N/A
- ALRN 2017
- Fundamental
- Price
- RSSS $3.08
- ALRN $2.58
- Analyst Decision
- RSSS Strong Buy
- ALRN Strong Buy
- Analyst Count
- RSSS 1
- ALRN 1
- Target Price
- RSSS $6.00
- ALRN $19.00
- AVG Volume (30 Days)
- RSSS 61.1K
- ALRN 87.4K
- Earning Date
- RSSS 11-14-2024
- ALRN 11-14-2024
- Dividend Yield
- RSSS N/A
- ALRN N/A
- EPS Growth
- RSSS N/A
- ALRN N/A
- EPS
- RSSS N/A
- ALRN N/A
- Revenue
- RSSS $46,607,410.00
- ALRN N/A
- Revenue This Year
- RSSS $13.84
- ALRN N/A
- Revenue Next Year
- RSSS $10.24
- ALRN N/A
- P/E Ratio
- RSSS N/A
- ALRN N/A
- Revenue Growth
- RSSS 19.26
- ALRN N/A
- 52 Week Low
- RSSS $2.21
- ALRN $1.61
- 52 Week High
- RSSS $3.50
- ALRN $7.42
- Technical
- Relative Strength Index (RSI)
- RSSS 71.77
- ALRN 29.28
- Support Level
- RSSS $2.81
- ALRN $2.67
- Resistance Level
- RSSS $3.16
- ALRN $3.11
- Average True Range (ATR)
- RSSS 0.13
- ALRN 0.38
- MACD
- RSSS 0.04
- ALRN -0.15
- Stochastic Oscillator
- RSSS 86.89
- ALRN 4.85
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.